Halozyme Therapeutics HALO Accounts Receivable And Contract With Customer Asset, After Allowance For Credit Loss, Current
Accounts Receivable And Contract With Customer Asset, After Allowance For Credit Loss, Current at other companies
Other financials
Where this comes from
Reported directly by Halozyme Therapeutics in its filing.
Tagged under the XBRL concept halo:AccountsReceivableAndContractWithCustomerAssetAfterAllowanceForCreditLossCurrent.
The official record: Halozyme Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Halozyme Therapeutics's accounts receivable and contract with customer asset, after allowance for credit loss, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Halozyme Therapeutics's accounts receivable and contract with customer asset, after allowance for credit loss, current?
- Halozyme Therapeutics (HALO) reported accounts receivable and contract with customer asset, after allowance for credit loss, current of $457.99M in Q1 2026.
- How has Halozyme Therapeutics's accounts receivable and contract with customer asset, after allowance for credit loss, current changed year-over-year?
- Halozyme Therapeutics's accounts receivable and contract with customer asset, after allowance for credit loss, current increased by 50.3% year-over-year, from $304.62M to $457.99M.
- What is the long-term trend for Halozyme Therapeutics's accounts receivable and contract with customer asset, after allowance for credit loss, current?
- Over 3 years (2022 to 2025), Halozyme Therapeutics's accounts receivable and contract with customer asset, after allowance for credit loss, current has grown at a 24.1% compound annual growth rate (CAGR), from $231.07M to $441.27M.
- What does accounts receivable and contract with customer asset, after allowance for credit loss, current mean?
- Money owed to the company by customers for products or services already provided.
- How do you interpret accounts receivable and contract with customer asset, after allowance for credit loss, current?
- A rising balance relative to revenue may indicate collection issues or aggressive revenue recognition, while a declining balance suggests efficient cash collection.
- How does accounts receivable and contract with customer asset, after allowance for credit loss, current compare across companies?
- Varies significantly based on payment terms and customer base concentration in the pharmaceutical and biotech sectors.